Lepu Medical Tech Beijing (300003) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lepu Medical Tech Beijing (300003) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.84 Million ≈ $62.31 Million USD) by net assets (CN¥17.75 Billion ≈ $2.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lepu Medical Tech Beijing - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Lepu Medical Tech Beijing's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300003 liabilities breakdown for a breakdown of total debt and financial obligations.
Lepu Medical Tech Beijing Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lepu Medical Tech Beijing ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
0.104x |
|
Wuchan Zhongda Group Co Ltd
SHG:600704
|
-0.088x |
|
Abercrombie & Fitch Company
NYSE:ANF
|
0.150x |
|
Shanghai AtHub Co Ltd
SHG:603881
|
0.117x |
|
Dalmia Bharat Limited
NSE:DALBHARAT
|
0.041x |
|
Bill Com Holdings Inc
NYSE:BILL
|
0.028x |
|
CSSC Offshore & Marine Engineering Group Co Ltd
SHG:600685
|
-0.073x |
|
Industrias CH S. A. B. de C. V
MX:ICHB
|
0.028x |
Annual Cash Flow Conversion Efficiency for Lepu Medical Tech Beijing (2006–2024)
The table below shows the annual cash flow conversion efficiency of Lepu Medical Tech Beijing from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Lepu Medical Tech Beijing.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥16.74 Billion ≈ $2.45 Billion |
CN¥734.64 Million ≈ $107.50 Million |
0.044x | -22.47% |
| 2023-12-31 | CN¥17.50 Billion ≈ $2.56 Billion |
CN¥990.36 Million ≈ $144.92 Million |
0.057x | -66.80% |
| 2022-12-31 | CN¥16.37 Billion ≈ $2.40 Billion |
CN¥2.79 Billion ≈ $408.37 Million |
0.170x | -31.67% |
| 2021-12-31 | CN¥12.27 Billion ≈ $1.80 Billion |
CN¥3.06 Billion ≈ $448.07 Million |
0.249x | +25.80% |
| 2020-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
CN¥2.09 Billion ≈ $305.79 Million |
0.198x | -20.24% |
| 2019-12-31 | CN¥8.00 Billion ≈ $1.17 Billion |
CN¥1.99 Billion ≈ $291.24 Million |
0.249x | +8.96% |
| 2018-12-31 | CN¥6.58 Billion ≈ $962.28 Million |
CN¥1.50 Billion ≈ $219.57 Million |
0.228x | +75.60% |
| 2017-12-31 | CN¥7.03 Billion ≈ $1.03 Billion |
CN¥913.13 Million ≈ $133.62 Million |
0.130x | +12.93% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.94 Million |
CN¥691.89 Million ≈ $101.25 Million |
0.115x | +40.74% |
| 2015-12-31 | CN¥5.34 Billion ≈ $781.21 Million |
CN¥436.46 Million ≈ $63.87 Million |
0.082x | -22.72% |
| 2014-12-31 | CN¥3.29 Billion ≈ $481.81 Million |
CN¥348.32 Million ≈ $50.97 Million |
0.106x | -7.14% |
| 2013-12-31 | CN¥2.89 Billion ≈ $423.55 Million |
CN¥329.76 Million ≈ $48.25 Million |
0.114x | +12.59% |
| 2012-12-31 | CN¥2.62 Billion ≈ $383.16 Million |
CN¥264.96 Million ≈ $38.77 Million |
0.101x | -18.63% |
| 2011-12-31 | CN¥2.34 Billion ≈ $342.64 Million |
CN¥291.20 Million ≈ $42.61 Million |
0.124x | -31.34% |
| 2010-12-31 | CN¥2.07 Billion ≈ $302.36 Million |
CN¥374.25 Million ≈ $54.76 Million |
0.181x | +32.64% |
| 2009-12-31 | CN¥1.76 Billion ≈ $256.95 Million |
CN¥239.79 Million ≈ $35.09 Million |
0.137x | -62.98% |
| 2008-12-31 | CN¥511.23 Million ≈ $74.81 Million |
CN¥188.59 Million ≈ $27.60 Million |
0.369x | +130.77% |
| 2007-12-31 | CN¥383.88 Million ≈ $56.17 Million |
CN¥61.37 Million ≈ $8.98 Million |
0.160x | -68.34% |
| 2006-12-31 | CN¥115.51 Million ≈ $16.90 Million |
CN¥58.32 Million ≈ $8.53 Million |
0.505x | -- |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide … Read more